Literature DB >> 31406391

The Anticipatory Politics of Improving Childhood Survival for Sickle Cell Disease.

Gina Jae1.   

Abstract

Crediting scientific discovery for prolonging life is pervasive in biomedical histories of the genetic blood disorder, sickle cell disease. This includes the preventive strategies, such as newborn screening, that have underwritten the success of its life-extending interventions. Newborn screening is a technology that relies not only upon intact health infrastructures but also expertise and enhanced vigilance on the part of caregivers to anticipate complications while they are still open to circumvention. This paper posits that even after overcoming institutional barriers to make newborn screening equitably available, care and vigilance are resources that are themselves subject to what i term anticipatory politics, where structural conditions also stratify expectations for the future, including the affective appeal of medical innovations. This paper elaborates the paradigm of anticipatory politics through an ethnographic examination of newborn screening to connect the comprehensive care practices that have improved survival for sickle cell disease, and as the burden of mortality shifts to young adulthood, to expose how those who are resourced to care for these futures preferentially stand to benefit from preventive interventions.

Entities:  

Keywords:  anticipation; care; expertise; newborn screening; politics; sickle cell disease

Year:  2018        PMID: 31406391      PMCID: PMC6690626          DOI: 10.1177/0162243918778342

Source DB:  PubMed          Journal:  Sci Technol Human Values        ISSN: 0162-2439


  13 in total

1.  Population estimates of sickle cell disease in the U.S.

Authors:  Kathryn L Hassell
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

2.  Matters of care in technoscience: assembling neglected things. .

Authors:  Maria Puig de la Bellacasa
Journal:  Soc Stud Sci       Date:  2011-02       Impact factor: 3.885

Review 3.  History and current status of newborn screening for hemoglobinopathies.

Authors:  Jane M Benson; Bradford L Therrell
Journal:  Semin Perinatol       Date:  2010-04       Impact factor: 3.300

4.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

5.  Newborn screening for sickle cell disease and other hemoglobinopathies. Newborn screening in New York City.

Authors:  R Grover
Journal:  Pediatrics       Date:  1989-05       Impact factor: 7.124

6.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Authors:  M H Gaston; J I Verter; G Woods; C Pegelow; J Kelleher; G Presbury; H Zarkowsky; E Vichinsky; R Iyer; J S Lobel
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

7.  Improved survival of children and adolescents with sickle cell disease.

Authors:  Charles T Quinn; Zora R Rogers; Timothy L McCavit; George R Buchanan
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

8.  Stem cell transplant for children with sickle cell anemia: parent and patient interest.

Authors:  Michael Roth; Julie Krystal; Deepa Manwani; Catherine Driscoll; Rosanna Ricafort
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-29       Impact factor: 5.742

9.  Mortality rates and age at death from sickle cell disease: U.S., 1979-2005.

Authors:  Sophie Lanzkron; C Patrick Carroll; Carlton Haywood
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

10.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

Authors:  Paul Telfer; Pietro Coen; Subarna Chakravorty; Olu Wilkey; Jane Evans; Heather Newell; Beverley Smalling; Roger Amos; Adrian Stephens; David Rogers; Fenella Kirkham
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

View more
  1 in total

Review 1.  Let's Get Back to Normal? COVID-19 and the Logic of Cure.

Authors:  Maria Berghs
Journal:  Front Sociol       Date:  2022-04-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.